Monument Capital Management’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$250K Sell
5,183
-74
-1% -$3.78K 0.05% 228
2026
Q2
$276K Hold
5,257
– – 0.06% 217
2026
Q1
$290K Buy
5,257
+152
+3% +$8.24K 0.07% 182
2025
Q4
$250K Buy
5,105
+467
+10% +$21.8K 0.06% 192
2025
Q3
$200K Buy
+4,638
New +$181K 0.05% 219

Other funds holding GSK

Monument Capital Management's GSK Position: Q3 2026 in Review

Monument Capital Management reduced its GSK (GSK) stake by 1.4% in Q3 2026, selling an estimated $3.78K and leaving 5,183 shares worth $250K. The position accounts for 0.05% of the portfolio, ranked #228.

Monument Capital Management first reported a position in GSK in Q3 2025 and has held it in 5 quarters since. The position peaked at $290K in Q1 2026. 993 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Monument Capital Management held 5,183 shares of GSK worth $250K as of Q3 2026.
  • Monument Capital Management sold 74 GSK shares in Q3 2026, an estimated $3.78K.
  • GSK made up 0.05% of Monument Capital Management's portfolio in Q3 2026, its #228 holding.
  • Monument Capital Management first reported a position in GSK in Q3 2025 and has held it in 5 quarters since.
  • Monument Capital Management's GSK position peaked at $290K in Q1 2026.
  • 993 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Monument Capital Management's 13F filing for Q3 2026, filed 9 Oct 2026.